Abstract
APS renal involvement was probably underestimated and not well characterized until recently. A possible explanation is that several manifestations of renal involvement (hypertension, hematuria, and proteinuria) were often neglected and that renal biopsy was rarely performed due to the frequent occurrence of thrombocytopenia and the use of anticoagulants among APS patients.
The true prevalence of renal involvement in APS is difficult to establish; in the few retrospective studies on large cohorts of APS patients, it is reported of 9–10 % but it is probably higher.
Renal involvement in APS is characterized by noninflammatory occlusion/thromboses of renal vessels (arterial and venous) ranging in size from large vessels to intrarenal microvasculature. In addition to vaso-occlusive abnormalities, other kinds of renal lesions such as glomerulonephritis have been reported in primary APS (PAPS). This heterogeneity of renal involvement could be explained by the presence of different underlying pathogenetic mechanisms.
From a clinical point of view, the most frequent signs and laboratory characteristics of APS renal involvement include hypertension, hematuria, acute renal failure, and progressive chronic renal insufficiency with mild to nephrotic range proteinuria. APS can also cause end-stage renal disease (rare) and allograft vascular thrombosis.
This chapter reviews the range of renal abnormalities associated with APS, their diagnosis, and treatment options.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hughes GR (1983) Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed) 87:1088–1089
Sinico RA, Cavazzana I, Nuzzo M et al (2010) Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients. Clin J Am Soc Nephrol 5:1211–1217
Vlachoyiannopoulos PG, Kanellopoulos P, Tektonidou M et al (2001) Renal involvement in antiphospholipid syndrome. Nephrol Dial Transplant 16(Suppl 6):60–62
Piette JC, Kleinknecht D, Bach JF (1996) Renal manifestations in the antiphospholipid syndrome. In: Asherson RA, Cervera R, Piette JC, Shonfield Y (eds) The antiphospholipid syndrome. CRC Press, Boca Raton, pp 169–181
Nochy D, Daugas E, Droz D et al (1999) The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 10:507–518
Fakhouri F, Noel LH, Zuber J et al (2003) The expanding spectrum of renal diseases associated with antiphospholipid syndrome. Am J Kidney Dis 41:1205–1211
Pons-Estel GJ, Cervera R (2014) Renal involvement in antiphospholipid syndrome. Curr Rheumatol Rep 16:397
Ostuni PA, Lazzarin P, Pengo V et al (1990) Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome. Ann Rheum Dis 49:184–187
Sangle SR, D’ Cruz DP, Jan W et al (2003) Renal artery stenosis in the antiphospholipid syndrome (Hughes) syndrome and hypertension. Ann Rheum Dis 62:999–1002
Delgado AJ, Kumar S, Isenberg DA (2003) Cross-reactivity between anticardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology 42:893–899
Tektonidou MG (2009) Renal involvement in the antiphospholipid syndrome (APS)-APS nephropathy. Clin Rev Allergy Immunol 36:131–140
Lim W, Crowther MA, Eikelboom JW (2006) Management of antiphospholipid antibody syndrome: a systematic review. JAMA 295:1050–1057
Sangle SR, D’ Cruz DP, Abbs IC et al (2005) Renal artery stenosis in hypertensive patients with antiphospholipid syndrome (Hughes syndrome): outcome following anticoagulation. Rheumatology 44:372–377
Rysana R, Zabka J, Peregin JH et al (1998) Acute renal failure due to bilateral renal artery thrombosis associated with primary antiphospholipid syndrome. Nephrol Dial Transplant 13:2645–2647
Asherson MA, Khamashta MA, Hughes GRV (1993) Hypertension and the antiphospholipid antibodies. Clin Exp Rheumatol 11:465–467
D’Cruz DP (2005) Renal manifestations of the antiphospholipid syndrome. Lupus 14:45–48
Tektonidou MG, Sotsiou F, Moutsopoulos HM (2008) Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary and systemic lupus erythematosus-related APS. J Rheumatol 35:1983–1988
D’Agati V, Kunis C, Williams G et al (1990) Anticardiolipin antibody and renal disease: a report of three cases. J Am Soc Nephrol 1:777–784
Amigo MC, Garcia-Torres R, Robles M et al (1992) Renal involvement in primary antiphospholipid syndrome. J Rheumatol 19:1181–1185
Banfi G, Bertani T, Boeri V et al (1991) Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Am J Kidney Dis 18:240–248
Cervera R, Tektonidou MG, Espinosa G et al (2011) Task force on Catastrophic Antiphospholipid Syndrome (APS) and non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus 20:165–173
Tsagalis G, Psimenou E, Nakopoulou L et al (2010) Effective treatment of antiphospholipid syndrome with plasmapheresis and rituximab. Hippokratia 14:215–216
Erkan D, Vega J, Ramon G et al (2013) A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome. Arthritis Rheum 65:464–471
Levy Y, Ziporen L, Gilburd B et al (1996) Membranous nephropathy in primary antiphospholipid syndrome: description of a case and induction of renal injury in SCID mice. Hum Antibodies Hybridomas 7:91–96
Erkan D, Yazici Y, Sobel R et al (2000) Primary antiphospholipid syndrome: functional outcome after 10 years. J Rheumatol 27:2817–2821
Gronhagen-Riska C, Teppo AM, Helantera A et al (1990) Raised concentrations of antibodies to cardiolipin in patients receiving dialysis. BMJ 300:1696–1697
Garcia-Martin F, De Arriba G, Carrascosa T et al (1991) Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease. Nephrol Dial Transplant 6:543–547
Domingues V, Dadhania D, Hartona C et al (2013) Hospital for special surgery—Cornell protocol for antiphospholipid antibody positive patients undergoing renal transplantation. In: 14th International Congress on Antiphospholipid Antibodies, Rio de Janeiro, 2013
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Mezzina, N., Sinico, R.A. (2015). Antiphospholipid Syndrome (APS) and the Renal Involvement. In: Meroni, P. (eds) Antiphospholipid Antibody Syndrome. Rare Diseases of the Immune System. Springer, Cham. https://doi.org/10.1007/978-3-319-11044-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-11044-8_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11043-1
Online ISBN: 978-3-319-11044-8
eBook Packages: MedicineMedicine (R0)